Koers Aeolus Pharmaceuticals, Inc. OTC Bulletin Board
Aandelen
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2015 | 3,11 mln. 2,87 mln. | Omzet 2016 | 2,08 mln. 1,91 mln. | Marktkapitalisatie | 28,9 mln. 26,62 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2015 | -2 mln. -1,84 mln. | Nettowinst (verlies) 2016 | -3 mln. -2,76 mln. | EV/omzet 2015 | 10,8 x |
Nettoschuld 2015 | 908K 836K | Nettoliquiditeiten 2016 | 3,16 mln. 2,91 mln. | EV/omzet 2016 | 12,4 x |
K/w-verhouding 2015 |
-12
x | K/w-verhouding 2016 |
-4,67
x | Werknemers | - |
Dividendrendement 2015 * |
-
| Dividendrendement 2016 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John McManus
CEO | Chief Executive Officer | 60 | 01-06-05 |
David Cavalier
CHM | Chairman | 54 | 30-04-04 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Cavalier
CHM | Chairman | 54 | 30-04-04 |
Jeffrey Scott
BRD | Director/Board Member | 67 | 08-05-13 |
John Clerici
BRD | Director/Board Member | 54 | 08-05-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+41,79% | 54,04 mld. | |
+45,60% | 41,96 mld. | |
-0,56% | 41,92 mld. | |
-7,20% | 28,35 mld. | |
+12,59% | 26,35 mld. | |
-21,51% | 19 mld. | |
+6,92% | 13 mld. | |
+29,60% | 12,28 mld. | |
+24,91% | 12,19 mld. |
- Beurs
- Aandelen
- Koers AOLS
- Koers